Ann: Paradigm to Present at Evercore ISI HealthCONx Conference, page-168

Funny, Vogelworld, I was going to type the same thing (but presumed you had me on block). We were never really that opposed in opinion on the other bio-tech (ironically poorly guided timelines too - absolutely its too common an issue in bio-techs) just essentially arguing about how big of an issue it was, like people are herein. This one is a little more overt in my opinion and lets hope the company does update their previously formally defined guidance accordingly, because the response Mozzarc got was simply not remotely sufficient if that is the official line.